Overview

Open Label Extension Study of Licarbazepine in the Treatment of Manic Episodes of Bipolar I Disorder

Status:
Completed
Trial end date:
2007-07-01
Target enrollment:
Participant gender:
Summary
This extension study is designed to assess the long-tem tolerability and safety of licarbazepine in patients who completed the 6-week double-blind study CLIC477D2303.
Phase:
Phase 4
Details
Lead Sponsor:
Novartis